Mariner
ROIV icon

Mariner’s Roivant Sciences ROIV Stock Holding History

Mariner’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5M Sell
141,242
-61,074
-30% -$1.8M 0.01% 1035
2026
Q1 		$5.6M Buy
202,316
+109,010
+117% +$2.8M 0.01% 1014
2025
Q4 		$2.02M Buy
93,306
+20,924
+29% +$413K ﹤0.01% 1499
2025
Q3 		$1.1M Buy
+72,382
New +$896K ﹤0.01% 1827
2025
Q2 		– Sell
-35,621
Closed -$359K – 3649
2025
Q1 		$359K Sell
35,621
-70,351
-66% -$761K ﹤0.01% 2473
2024
Q4 		$1.25M Buy
105,972
+20,299
+24% +$240K ﹤0.01% 1499
2024
Q3 		$989K Buy
85,673
+60,600
+242% +$690K ﹤0.01% 1611
2024
Q2 		$265K Sell
25,073
-334
-1% -$3.66K ﹤0.01% 2552
2024
Q1 		$268K Buy
25,407
+9,160
+56% +$98.8K ﹤0.01% 2541
2023
Q4 		$182K Buy
+16,247
New +$158K ﹤0.01% 2714

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Mariner's ROIV Position: Q2 2026 in Review

Mariner reduced its Roivant Sciences (ROIV) stake by 30% in Q2 2026, selling an estimated $1.8M and leaving 141,242 shares worth $5M. The position accounts for 0.01% of the portfolio, ranked #1035.

Mariner first reported a position in ROIV in Q4 2023 and has held it in 10 quarters since. The position peaked at $5.6M in Q1 2026. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Mariner held 141,242 shares of Roivant Sciences worth $5M as of Q2 2026.
  • Mariner sold 61,074 Roivant Sciences shares in Q2 2026, an estimated $1.8M.
  • Roivant Sciences made up 0.01% of Mariner's portfolio in Q2 2026, its #1035 holding.
  • Mariner first reported a position in Roivant Sciences in Q4 2023 and has held it in 10 quarters since.
  • Mariner's Roivant Sciences position peaked at $5.6M in Q1 2026.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.